Journal article

A global investment framework for the elimination of hepatitis B

Jessica Howell, Alisa Pedrana, Sophia E Schroeder, Nick Scott, Lisa Aufegger, Rifat Atun, Ricardo Baptista-Leite, Gottfried Hirnschall, Ellen 't Hoen, Sharon J Hutchinson, Jeffrey Lazarus, Lesi Olufunmilayo, Raquel Peck, Manik Sharma, Annette H Sohn, Alexander Thompson, Mark Thursz, David Wilson, Margaret Hellard



BACKGROUND & AIMS: More than 292 million people are living with hepatitis B worldwide and are at risk of death from cirrhosis and liver cancer. The World Health Organization (WHO) has set global targets for the elimination of viral hepatitis as a public health threat by 2030. However, current levels of global investment in viral hepatitis elimination programmes are insufficient to achieve these goals. METHODS: To catalyse political commitment and to encourage domestic and international financing, we used published modelling data and key stakeholder interviews to develop an investment framework to demonstrate the return on investment for viral hepatitis elimination. RESULTS: The framework uti..

View full abstract


Funding Acknowledgements

The Burnet Institute received funding from the Qatar Foundation as part of their support for the World Innovations Summit for Health, 2018.